$76.29
2.263.06%
Last update: Nov 4, 11:14 AM
BridgeBio Pharma Inc
BBIONASDAQ
BridgeBio Pharma (BBIO) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.57 | $-0.59 | $-0.63 | $-0.67 |
| Actual | $-0.42 | $-0.78 | $-0.84 | $-1.00 |
| Surprise | +26.3% | -32.2% | -33.3% | -49.3% |
| Revenue | ||||
| Estimate | $295.9M | $220.3M | $178.8M | $149.5M |
| Actual | $353.2M | $243.7M | $194.5M | $154.2M |
| Surprise | +19.4% | +10.6% | +8.76% | +3.16% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.50 | $-0.32 | $-0.19 | $0.02 |
| Revenue | ||||
| Consensus | $305.0M | $336.0M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $-0.42 | $-0.57 | 26.3 % |
| Q2 | Aug 10, 2026 | $-0.78 | $-0.59 | -32.2 % |
| Q1 | May 7, 2026 | $-0.84 | $-0.63 | -33.3 % |
| Q4 | Feb 24, 2026 | $-1.00 | $-0.67 | -49.3 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 29, 2026 | $353.17M | $295.92M | 19.4 % |
| Q2 | Aug 10, 2026 | $243.68M | $220.30M | 10.6 % |
| Q1 | May 7, 2026 | $194.52M | $178.85M | 8.76 % |
| Q4 | Feb 24, 2026 | $154.18M | $149.45M | 3.16 % |
